Integrative analysis of genetic data sets reveals a shared innate immune component in autism spectrum disorder and its co-morbidities

Background Autism spectrum disorder (ASD) is a common neurodevelopmental disorder that tends to co-occur with other diseases, including asthma, inflammatory bowel disease, infections, cerebral palsy, dilated cardiomyopathy, muscular dystrophy, and schizophrenia. However, the molecular basis of this...

Full description

Bibliographic Details
Main Authors: Palmer, Nathan P., Kohane, Isaac S., Nazeen, Sumaiya, Berger Leighton, Bonnie
Other Authors: Massachusetts Institute of Technology. Computer Science and Artificial Intelligence Laboratory
Format: Article
Language:English
Published: BioMed Central 2016
Online Access:http://hdl.handle.net/1721.1/105756
https://orcid.org/0000-0002-6313-6357
https://orcid.org/0000-0002-2724-7228
_version_ 1826195791806464000
author Palmer, Nathan P.
Kohane, Isaac S.
Nazeen, Sumaiya
Berger Leighton, Bonnie
author2 Massachusetts Institute of Technology. Computer Science and Artificial Intelligence Laboratory
author_facet Massachusetts Institute of Technology. Computer Science and Artificial Intelligence Laboratory
Palmer, Nathan P.
Kohane, Isaac S.
Nazeen, Sumaiya
Berger Leighton, Bonnie
author_sort Palmer, Nathan P.
collection MIT
description Background Autism spectrum disorder (ASD) is a common neurodevelopmental disorder that tends to co-occur with other diseases, including asthma, inflammatory bowel disease, infections, cerebral palsy, dilated cardiomyopathy, muscular dystrophy, and schizophrenia. However, the molecular basis of this co-occurrence, and whether it is due to a shared component that influences both pathophysiology and environmental triggering of illness, has not been elucidated. To address this, we deploy a three-tiered transcriptomic meta-analysis that functions at the gene, pathway, and disease levels across ASD and its co-morbidities. Results Our analysis reveals a novel shared innate immune component between ASD and all but three of its co-morbidities that were examined. In particular, we find that the Toll-like receptor signaling and the chemokine signaling pathways, which are key pathways in the innate immune response, have the highest shared statistical significance. Moreover, the disease genes that overlap these two innate immunity pathways can be used to classify the cases of ASD and its co-morbidities vs. controls with at least 70 % accuracy. Conclusions This finding suggests that a neuropsychiatric condition and the majority of its non-brain-related co-morbidities share a dysregulated signal that serves as not only a common genetic basis for the diseases but also as a link to environmental triggers. It also raises the possibility that treatment and/or prophylaxis used for disorders of innate immunity may be successfully used for ASD patients with immune-related phenotypes. Keywords Autism spectrum disorder Co-morbidities of ASD Innate immunity pathways Three-tiered meta-analysis Gene expression
first_indexed 2024-09-23T10:15:30Z
format Article
id mit-1721.1/105756
institution Massachusetts Institute of Technology
language English
last_indexed 2024-09-23T10:15:30Z
publishDate 2016
publisher BioMed Central
record_format dspace
spelling mit-1721.1/1057562022-09-26T16:50:14Z Integrative analysis of genetic data sets reveals a shared innate immune component in autism spectrum disorder and its co-morbidities Palmer, Nathan P. Kohane, Isaac S. Nazeen, Sumaiya Berger Leighton, Bonnie Massachusetts Institute of Technology. Computer Science and Artificial Intelligence Laboratory Nazeen, Sumaiya Berger Leighton, Bonnie Background Autism spectrum disorder (ASD) is a common neurodevelopmental disorder that tends to co-occur with other diseases, including asthma, inflammatory bowel disease, infections, cerebral palsy, dilated cardiomyopathy, muscular dystrophy, and schizophrenia. However, the molecular basis of this co-occurrence, and whether it is due to a shared component that influences both pathophysiology and environmental triggering of illness, has not been elucidated. To address this, we deploy a three-tiered transcriptomic meta-analysis that functions at the gene, pathway, and disease levels across ASD and its co-morbidities. Results Our analysis reveals a novel shared innate immune component between ASD and all but three of its co-morbidities that were examined. In particular, we find that the Toll-like receptor signaling and the chemokine signaling pathways, which are key pathways in the innate immune response, have the highest shared statistical significance. Moreover, the disease genes that overlap these two innate immunity pathways can be used to classify the cases of ASD and its co-morbidities vs. controls with at least 70 % accuracy. Conclusions This finding suggests that a neuropsychiatric condition and the majority of its non-brain-related co-morbidities share a dysregulated signal that serves as not only a common genetic basis for the diseases but also as a link to environmental triggers. It also raises the possibility that treatment and/or prophylaxis used for disorders of innate immunity may be successfully used for ASD patients with immune-related phenotypes. Keywords Autism spectrum disorder Co-morbidities of ASD Innate immunity pathways Three-tiered meta-analysis Gene expression National Institutes of Health (U.S.) (grant GM081871) Massachusetts Institute of Technology. Ludwig Center for Molecular Oncology United States. J. William Fulbright Foreign Scholarship Board (International Fulbright Science and Technology Fellowship) 2016-12-08T20:21:49Z 2016-12-08T20:21:49Z 2016-11 2016-07 2016-11-15T04:40:24Z Article http://purl.org/eprint/type/JournalArticle 1474-760X http://hdl.handle.net/1721.1/105756 Nazeen, Sumaiya et al. “Integrative Analysis of Genetic Data Sets Reveals a Shared Innate Immune Component in Autism Spectrum Disorder and Its Co-Morbidities.” Genome Biology 17.1 (2016): n. pag. https://orcid.org/0000-0002-6313-6357 https://orcid.org/0000-0002-2724-7228 en http://dx.doi.org/10.1186/s13059-016-1084-z Genome Biology Creative Commons Attribution http://creativecommons.org/licenses/by/4.0/ The Author(s) application/pdf BioMed Central BioMed Central
spellingShingle Palmer, Nathan P.
Kohane, Isaac S.
Nazeen, Sumaiya
Berger Leighton, Bonnie
Integrative analysis of genetic data sets reveals a shared innate immune component in autism spectrum disorder and its co-morbidities
title Integrative analysis of genetic data sets reveals a shared innate immune component in autism spectrum disorder and its co-morbidities
title_full Integrative analysis of genetic data sets reveals a shared innate immune component in autism spectrum disorder and its co-morbidities
title_fullStr Integrative analysis of genetic data sets reveals a shared innate immune component in autism spectrum disorder and its co-morbidities
title_full_unstemmed Integrative analysis of genetic data sets reveals a shared innate immune component in autism spectrum disorder and its co-morbidities
title_short Integrative analysis of genetic data sets reveals a shared innate immune component in autism spectrum disorder and its co-morbidities
title_sort integrative analysis of genetic data sets reveals a shared innate immune component in autism spectrum disorder and its co morbidities
url http://hdl.handle.net/1721.1/105756
https://orcid.org/0000-0002-6313-6357
https://orcid.org/0000-0002-2724-7228
work_keys_str_mv AT palmernathanp integrativeanalysisofgeneticdatasetsrevealsasharedinnateimmunecomponentinautismspectrumdisorderanditscomorbidities
AT kohaneisaacs integrativeanalysisofgeneticdatasetsrevealsasharedinnateimmunecomponentinautismspectrumdisorderanditscomorbidities
AT nazeensumaiya integrativeanalysisofgeneticdatasetsrevealsasharedinnateimmunecomponentinautismspectrumdisorderanditscomorbidities
AT bergerleightonbonnie integrativeanalysisofgeneticdatasetsrevealsasharedinnateimmunecomponentinautismspectrumdisorderanditscomorbidities